TriSalus Life Sciences In...
(TLSI)
undefined
undefined%
At close: undefined
5.04
0.00%
After-hours Jan 06, 2025, 04:00 PM EST
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 |
| PE Ratio | -1.34 | -6.29 | -10.7 | -10.1 |
| PS Ratio | 4.29 | 23.95 | 36.75 | 59.16 |
| PB Ratio | -3.06 | -1.68 | -2.38 | 1.41 |
| P/FCF Ratio | -1.55 | -8.97 | -12.89 | -262.96 |
| P/OCF Ratio | -1.59 | -9.19 | -13.6 | -474.47 |
| OCF/S Ratio | -2.7 | -2.61 | -2.7 | -0.12 |
| Debt / Equity Ratio | n/a | n/a | -0.00 | 0.18 |
| Quick Ratio | 1.25 | 0.49 | 5.31 | 13.96 |
| Current Ratio | 1.42 | 0.53 | 5.51 | 19.46 |
| Asset Turnover | 0.72 | 0.56 | 0.22 | 0.02 |
| Interest Coverage | -3.38K | -36.44K | -13.65 | n/a |
| Return on Equity (ROE) | 2.28 | 0.27 | 0.22 | -0.14 |
| Return on Assets (ROA) | -2.29 | -2.15 | -0.76 | -0.13 |
| Return on Capital (ROIC) | -4.91 | 3.52 | -0.76 | -0.1 |
| Dividend Yield | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 85.93% | 81.79% | 85.80% | 59.55% |
| Net Profit Margin | -318.93% | -380.6% | -343.35% | -585.76% |
| Pretax Profit Margin | -318.89% | -380.53% | -343.32% | -585.68% |
| Operating Profit Margin | -292.53% | -293.91% | -286.06% | -471.95% |
| FCF Margin | -276.41% | -266.97% | -285.14% | -22.5% |
| EBITDA Margin | -314.94% | -377.18% | -280.54% | -466.05% |